Anindita Banerjee Selected Research

calceolarioside A

4/2008

In vivo efficacy of calceolarioside A against experimental visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anindita Banerjee Research Topics

Disease

6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 03/2013
5	Crohn Disease (Crohn's Disease) 01/2022 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2013
2	Alopecia (Baldness) 01/2022 - 01/2021
2	Alopecia Areata 01/2022 - 01/2021
2	COVID-19 10/2021 - 05/2020
2	Ulcer 01/2020 - 10/2018
2	Dementia (Dementias) 06/2019 - 02/2017
2	Necrosis 01/2019 - 10/2018
2	Prediabetic State (Prediabetes) 01/2018 - 06/2017
2	Diabetes Mellitus 06/2017 - 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Obesity 06/2021
1	Weight Loss (Weight Reduction) 06/2021
1	Hyperlipidemias (Hyperlipidemia) 10/2020
1	Hyperglycemia 10/2020
1	Wounds and Injuries (Trauma) 02/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Human Influenza (Influenza) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Schizophrenia (Dementia Praecox) 11/2019
1	Psychotic Disorders (Schizoaffective Disorder) 11/2019
1	Dystonia (Limb Dystonia) 11/2019
1	Vomiting 10/2019
1	Dehydration (Water Stress) 10/2019
1	Gastroenteritis 10/2019
1	Neoplasms (Cancer) 09/2019
1	Fibrosarcoma 01/2019
1	Body Weight (Weight, Body) 06/2017
1	Insulin Resistance 06/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2017
1	Hypercholesterolemia 08/2015
1	Hyperhomocysteinemia 08/2015
1	Sensorineural Hearing Loss 07/2015
1	Vitamin D Deficiency 01/2015
1	Brain Diseases (Brain Disorder) 10/2014
1	Inflammation (Inflammations) 01/2013
1	Visceral Leishmaniasis (Kala Azar) 04/2008
1	Infarction (Infarctions) 05/2007
1	Myocardial Infarction 05/2007

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2017
5	Vitamin D FDA LinkGeneric 10/2021 - 01/2015
4	Monoclonal AntibodiesIBA 01/2022 - 01/2018
4	ontamalimabIBA 01/2022 - 01/2018
3	Cell Adhesion Molecule-1IBA 01/2022 - 01/2018
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2021
2	SaltsIBA 01/2022 - 01/2021
2	Biological ProductsIBA 05/2020 - 03/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 10/2018
2	VaccinesIBA 01/2020 - 10/2019
2	C-Reactive ProteinIBA 01/2020 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 09/2019 - 03/2013
2	AdiponectinIBA 01/2018 - 06/2017
2	CytokinesIBA 05/2017 - 08/2015
2	AntioxidantsIBA 02/2017 - 03/2013
1	Tec protein-tyrosine kinaseIBA 01/2022
1	Janus KinasesIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022
1	Liraglutide FDA Link 06/2021
1	coumarinIBA 01/2021
1	LigandsIBA 01/2021
1	Retinaldehyde (Retinal)IBA 10/2020
1	Biological FactorsIBA 05/2020
1	PhytochemicalsIBA 02/2020
1	Methanol (Carbinol)IBA 02/2020
1	Streptozocin (Streptozotocin)FDA Link 02/2020
1	SynucleinsIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	IronIBA 01/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2019
1	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2019
1	2- ((4- (1- methyl- 4- pyridin- 4- yl- 1H- pyrazol- 3- yl)phenoxy)methyl)quinolineIBA 11/2019
1	Antipsychotic Agents (Antipsychotics)IBA 11/2019
1	24-hydroxycholesterolIBA 06/2019
1	CollagenIBA 01/2019
1	PF-04236921IBA 01/2019
1	bunazosin (Andante)IBA 01/2019
1	IntegrinsIBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Cell Adhesion MoleculesIBA 10/2018
1	Hormones (Hormone)IBA 06/2017
1	hydroxide ionIBA 06/2017
1	Insulin (Novolin)FDA Link 06/2017
1	Glucose (Dextrose)FDA LinkGeneric 06/2017
1	Nootropic Agents (Nootropics)IBA 02/2017
1	Amyloid beta-PeptidesIBA 05/2016
1	AdipokinesIBA 08/2015
1	AcidsIBA 07/2015
1	PF-04958242IBA 07/2015
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 10/2014
1	Amyloid (Amyloid Fibrils)IBA 03/2013
1	Adenosine DeaminaseIBA 01/2013
1	calceolarioside AIBA 04/2008

Therapy/Procedure

3	Therapeutics 06/2021 - 01/2015
1	Length of Stay 10/2019
1	Aftercare (After-Treatment) 01/2018